United States FDA has recently granted approval for Pivya (pivmecillinam) as a treatment option for recurrent UTIs, marking a significant development in combating this common condition. ...

FDA has approved Casgevy, marking a historic moment as the first-ever CRISPR-based medicine to receive the green light for treating beta-thalassemia. ...

FDA clears AstraZeneca's Truqap for advanced breast cancer treatment, targeting specific gene mutations. ...

Advisers to the Food and Drug Administration (FDA) will evaluate a gene therapy for sickle cell disease. ...

FDA cautions against using probiotic products for preterm infants, citing potential life-threatening health risks, in the wake of a recent preterm baby's death. ...